ADC Therapeutics SA - notizie pubblicate 183 - letture 4.633


ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates - Form 8-K

Adc therapeutics reports fourth quarter and full year 2023 financial results and provides business updates zynlonta® (loncastuximab tesirine-lpyl) net sales of $16.6 million in 4q ...

13.03.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

View all news adc therapeutics reports fourth quarter and full year 2023 financial results and provides business updates march 13, 2024 zynlonta® (loncastuximab tesirine-lpyl) net ...

13.03.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit

View all news adc therapeutics to participate in the guggenheim 5th annual healthy altitudes summit march 06, 2024 lausanne, switzerland, march 06, 2024 (globe newswire) -- adc the ...

06.03.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024

View all news adc therapeutics to host fourth quarter and year-end 2023 financial results conference call on march 13, 2024 march 06, 2024 lausanne, switzerland, march 06, 2024 (gl ...

06.03.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting

View all news adc therapeutics announces abstracts accepted for presentation at the american association for cancer research (aacr) annual meeting march 05, 2024 preclinical data s ...

05.03.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

TD Cowen Healthcare Conference

Adc therapeutics business overview cowen conference march 5, 2024 forward-looking statements this presentation and any accompanying oral presentation have been prepared by adc ther ...

05.03.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Regulation FD Presentation - Form 8-K

The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer adc therapeutics sa ...

05.03.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Management Change/Compensation - Form 8-K

Item 5.02 departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. on february 23, 2024, t ...

29.02.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

View all news adc therapeutics to participate in the td cowen 44th annual health care conference february 27, 2024 download(opens in new window) view all news attachments original ...

27.02.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Statement of Changes in Beneficial Ownership - Form 4

Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...

10.02.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Initial Statement of Beneficial Ownership - Form 3

Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...

10.02.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Material Agreement - Form 8-K

Item 1.01. entry into a material definitive agreement. on january 18, 2024, adc therapeutics sa (the "company") entered into an agreement (the "redmile agreement&quo ...

24.01.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Material Agreement - Form 8-K

Item 1.01. entry into a material definitive agreement. amendment to the loan agreement on january 16, 2024, the company and certain of its subsidiaries entered into the first amend ...

19.01.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Business Update

Business update january 4, 2024 forward-looking statements this presentation and any accompanying oral presentation have been prepared by adc therapeutics sa ("adc therapeutic ...

04.01.2024
ADC Therapeutics SA

ADC THERAPEUTICS SA

Material Event - Form 8-K

Item 8.01. other events. on january 2, 2024, adc therapeutics sa (the "company") received a notice from the new york stock exchange ("nyse") that the company ha ...

04.01.2024
Condividi